Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Novacyt de volgende biotech raket!
Volgen
voda schreef op 7 september 2023 08:59 :
Ik kwam vorige week dinsdag terug uit het buitenland, en voelde mij woensdag niet goed. De klachten hielden een paar dagen aan. Ben naar het ziekenhuis voor een test geweest en had corona. Volgens de arts waren er al vele besmette personen. Heb nu geen klachten meer. Had al eerder in 2020 corona gehad, en dacht dat ik voldoende anti stoffen zou hebben, niet dus. Heb geen vaccinaties gehad. Mijn partner wel, maar kreeg ook corona.
Beterschap Hans!
The CDC is preparing for a winter with '3 bugs out there': Covid, flu and RSV. Vaccine fatigue is already here, although many Americans will be urged to get three different shots this fall. Lees verder op:www.nbcnews.com/health/health-news/tr...
Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Completion of acquisition of Yourgene Health plc and Board appointments Acquisition adds scale and diversification to create a stronger global diagnostics business, with a complementary suite of genomic technologies and services Paris, France and Eastleigh, UK – 8 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the completion of the acquisition by Novacyt UK Holdings Limited ("Novacyt UK"), a wholly-owned subsidiary of Novacyt, of the entire share capital of Yourgene Health plc (“Yourgene”), an international molecular diagnostic group (the “Acquisition”). The Acquisition has been implemented by way of a scheme of arrangement between Yourgene and its shareholders under Part 26 of the UK Companies Act 2006 (the "Scheme"). Further to the announcements made by the Company and Yourgene on 7 September 2023, that the Court had sanctioned the Scheme, the Company is pleased to announce that, following delivery of the Court Order to the Registrar of Companies today, the Scheme has now become Effective in accordance with its terms and accordingly, Novacyt UK is now the owner of the entire issued share capital of Yourgene. Yourgene’s announcement regarding the Scheme becoming Effective, including details on settlement and the timing for the suspension of trading and subsequent delisting and cancellation of admission to trading on AIM for Yourgene Shares can be viewed here: polaris.brighterir.com/public/yourgenehealth/news/rns/story/rmv3q2r Yourgene is an international integrated technologies and services business, enabling the delivery of genomic medicine. It primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic and screening solutions, for reproductive health and precision medicine. Yourgene's portfolio of in vitro diagnostic products includes non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests and DPYD genotyping assays. Yourgene is headquartered in Manchester, UK with offices in Taipei (divestment pending), Singapore, the U.S. and Canada. The Acquisition is a key strategic milestone for Novacyt, creating a larger, specialist international diagnostics company, adding scale and diversification to accelerate revenue growth and build long term value. The Enlarged Group will have a broader product portfolio and complementary expertise, strengthening the Company’s market position and enabling Novacyt to deliver more integrated solutionsto its customers. With Novacyt’sstrong financial position and complementary resources, the Novacyt Board believes the Company is well-placed to accelerate the growth of Yourgene’s core NIPT offering, Ranger® Technology and PCR portfolio to the benefit of the Enlarged Group. In accordance with the terms of the Acquisition, both Dr John Brown and Lyn Rees (Yourgene’s former Chairman and CEO respectively) will join the board of Novacyt as non-executive and executive director respectively, first as non-voting members, then as full members, subject to shareholder ratification at the next AGM. James McCarthy, Acting Group CEO of Novacyt, commented: “The acquisition of Yourgene is an important strategic milestone for Novacyt, broadening the scale and depth of our expertise and adding a complementary suite of products and services in the exciting area of genomic medicine. I am delighted to welcome Lyn and his team to Novacyt and look forward to working together as we continue to develop new innovative diagnostic solutions to improve healthcare outcomes and drive the growth of the business.” Commenting on the Acquisition, Lyn Rees, Chief Executive Officer of Yourgene, said: "I am excited to join the Novacyt team and look forward to continuing the evolution of Yourgene and the Enlarged Group. With the combined resources and expertise within the Enlarged Group, we are well placed to unlock the full potential of our technologies and services and deliver greater value to our customers." Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in Part VII of the scheme document published by Yourgene on 27 July 2023 in connection with the Scheme. Regulatory Disclosures Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules for Companies in respect of the appointments of Mr John Robert Brown, aged 68, and Mr Lyn Dafydd Rees, aged 50. Voor meer, zie link:novacyt.com/completion-of-acquisition...
Louis7 schreef op 8 september 2023 11:14 :
[...]
Beterschap Hans!
Bedankt Louis. Ik heb bijna geen klachten meer. Hooguit nog een beetje snuiten, maar dat is minimaal.
Veel beterschap Hans ; we zijn nog niet van dat beestje verlost. Novacyt schijnt een pauze te nemen. De vaccinproducent Novavax maakt bokkensprongen. Toch denk ik dat zowel Novacyt als Novavax een grote sprong voorwaarts kunnen maken. Je voelt dat na de hitte, in de herfst het beestje weer zal opduiken. Nogmaals, niet dat ik erop hoop, maar ik kijk gewoon naar de feiten. Hans is besmet, net als de First Lady : dat zijn per slot van rekening toch twee zeer belangrijke mensen...
Riding the Tiger schreef op 8 september 2023 16:38 :
Veel beterschap Hans ; we zijn nog niet van dat beestje verlost.
Novacyt schijnt een pauze te nemen. De vaccinproducent Novavax maakt bokkensprongen. Toch denk ik dat zowel Novacyt als Novavax een grote sprong voorwaarts kunnen maken. Je voelt dat na de hitte, in de herfst het beestje weer zal opduiken. Nogmaals, niet dat ik erop hoop, maar ik kijk gewoon naar de feiten. Hans is besmet, net als de First Lady : dat zijn per slot van rekening toch twee zeer belangrijke mensen...
Maak je maar geen illusies: het grootschalige testen zal nooit meer terugkomen. Novachit zal een ander verdienmodel moeten vinden.
Echt DZR, die negatieve one-liners voegen niets toe. (en ook niet op vele andere fora)
Slotkoers 31 dec. 2022 1,2295 Slotkoers 06 jan. 2023 1,0355 -0,194 = -15.78% Enorm volatiele week. Slotkoers 13 jan. 2023 0,943 -0,0925 = -8.93% Slotkoers 20 jan. 2023 0,8866 -0,0564 = -5.98% Slotkoers 27 jan. 2023 0,853 -0,0336 = -3.79% Slotkoers 03 feb. 2023 0,7768 -0,0762 = -8.93% Slotkoers 10 feb. 2023 0,7534 -0,0234 = -3.01% Slotkoers 17 feb. 2023 0,72 -0,0334 = -4.43% Slotkoers 24 feb. 2023 0,7362 +0,0162 = +2.25% De eerste week met een PLUSJE Slotkoers 03 mrt. 2023 0,6938 -0,0424 = -5.76% Slotkoers 10 mrt. 2023 0,66 -0,0338 = -4.87% Slotkoers 17 mrt. 2023 0,6206 -0,0394 = -5.97% Slotkoers 24 mrt. 2023 0,612 -0,0086 = -1.39% Slotkoers 31 mrt. 2023 0,64 +0,028 = +4.58% Slotkoers 06 apr. 2023 0,625 -0,015 = -2.34% Slotkoers 14 apr. 2023 0,6335 +0,085 = +1.36% Slotkoers 21 apr. 2023 0,591 -0,0425 = -6.71% Slotkoers 28 apr. 2023 0,5625 -0,0285 = -4.82% PB Finale eindcijfers 2022 Slotkoers 05 mei 2023 0,5175 -0,045 = -8.00% Slotkoers 12 mei 2023 0,499 -0,0185 = -3.57% Slotkoers 19 mei 2023 0,479 -0,02 = -4.01% Slotkoers 26 mei 2023 0,4662 -0,0128 = -2.67% Slotkoers 02 jun. 2023 0,481 +0,0148 = +3.17% Eindelijk een ommekeer? Slotkoers 09 jun. 2023 0,496 +0,015 = +3.12% Slotkoers 16 jun. 2023 0,4612 -0,0348 = -7.02% Slotkoers 23 jun. 2023 0,4406 -0,0206 = -4.47% Slotkoers 30 jun. 2023 0,4238 -0,0168 = -3.81% Slotkoers 07 jul. 2023 0,4788 +0,055 = +12.98% PB Overname Yourgene (Top was 0,59 ruim 40%) Slotkoers 14 jul. 2023 0,515 +0,0362 = +7.56% Slotkoers 21 jul. 2023 0,54 +0,025 = +4.85% Slotkoers 28 jul. 2023 0,716 +0,176 = +32.59% PB Trading update 1 st halfyear. Slotkoers 04 aug. 2023 0,725 +0,009 = +1.26% Slotkoers 11 aug. 2023 0,888 +0,163 = +22.48% Slotkoers 18 aug. 2023 0,931 +0,043 = +4.84% PB Overname Yourgene akkoord. Slotkoers 25 aug. 2023 0,866 -0,065 = -6.98% Slotkoers 01 sep. 2023 0,86 -0,006 = -0.69% Slotkoers 08 sep. 2023 0,931 +0,071 = +8.26% PB Yourgene Jaarrendement t.o.v. van 31 december 2022 -0,2985 = -24.28% Maandrendementen: (t.o.v. slot vorige maand) Slotkoers 31 jan. 2023 0,8084 -0,4211 = -34.25% Slotkoers 28 feb. 2023 0,709 -0,0994 = -12.30% Slotkoers 31 mrt. 2023 0,64 -0,069 = -9.73% Slotkoers 28 apr. 2023 0,5625 -0,0775 = -12.11% Slotkoers 31 mei 2023 0,466 -0,0965 = -17.16% Slotkoers 30 jun. 2023 0,4238 -0,0422 = -9.06% Slotkoers 31 jul. 2023 0,7295 +0.3057 = +72.13!!% Slotkoers 31 aug. 2023 0,885 +0,1555 = +21.32% Slotkoers 08 sep. 2023 0,931 +0,046 = +5.20%
Klein deeltje in de portefeuille, daarentegen 37% in de plus. ;) MET Dank aan zwarte ridder.
€URO-Trader schreef op 8 september 2023 22:43 :
Klein deeltje in de portefeuille, daarentegen 37% in de plus. ;) MET Dank aan zwarte ridder.
Graag gedaan....!!!!
Ha Hans, hoe gaat het nu?
Popina schreef op 9 september 2023 10:36 :
Ha Hans, hoe gaat het nu?
Prima, totaal geen klachten meer. Voel mij weer helemaal pico bello. :-) Bedankt voor het vragen.
Hier in de nabijheid ook meer gevallen, noorden Dordogne
Popina schreef op 9 september 2023 10:44 :
Hier in de nabijheid ook meer gevallen, noorden Dordogne
Geweldig nieuws voor Novachit......!!!
PBos schreef op 11 september 2023 08:50 :
www.bbc.com/news/uk-scotland-66767409... Nog meer goed nieuws voor Novacyt....!!! Zijn er nog personen die denken dat de UK overheid ooit nog covidtesten bij Novacyt gaat bestellen......????
11 Sep De-listing and cancellation of trading of Yourgene Shares in Board, Novacyt Group Paris, France and Eastleigh, UK – 11 September 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, notes today’s announcement by Yourgene Health plc (“Yourgene”), in relation to the recommended cash offer made by Novacyt UK Holdings Limited (“Novacyt UK”), a wholly-owned subsidiary of Novacyt, for the entire issued and to be issued share capital of Yourgene announced on 3 July 2023 (the “Acquisition”), which is to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the “Scheme”). Further to the announcement made by Yourgene on 8 September 2023 that the Scheme has now become Effective in accordance with its terms, Yourgene has today announced that, following an application to the London Stock Exchange, the admission to trading on AIM of Yourgene Shares has been cancelled with effect from 7.00 a.m. today, 11 September 2023. De-listing and cancellation of trading of Yourgene Sharesnovacyt.com/de-listing-and-cancellati...
En nu maar hopen dat de nieuwe aandeelhouders hun aandelen niet gelijk gaan dumpen..........
DeZwarteRidder schreef op 11 september 2023 09:23 :
En nu maar hopen dat de nieuwe aandeelhouders hun aandelen niet gelijk gaan dumpen..........
dat verkondig je al dagen, weken, maanden en jaren. Daar koopt men niks voor.
Toch nog een leuk slot zo! 0,9500 +0,0190 / +2,04% 17:35:59
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee